Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NCOMP--a windows-based computer program for noncompartmental analysis of pharmacokinetic data

P B Laub1, J M Gallo

  • 1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Journal of Pharmaceutical Sciences
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2017
Same author

Multiscale design of cell-type-specific pharmacokinetic/pharmacodynamic models for personalized medicine: application to temozolomide in brain tumors.

CPT: pharmacometrics & systems pharmacology·2014
Same author

Mechanistic vs. Empirical network models of drug action.

CPT: pharmacometrics & systems pharmacology·2014
Same author

A General Network Pharmacodynamic Model-Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR Pathway.

CPT: pharmacometrics & systems pharmacology·2014
Same author

Physiologically based pharmacokinetic models of tyrosine kinase inhibitors: a systems pharmacological approach to drug disposition.

Clinical pharmacology and therapeutics·2013
Same author

Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2007

NCOMP is a Windows program for pharmacokinetic analysis, simplifying noncompartmental analysis (NCA) for intravenous bolus, continuous infusion, and oral drug administration. It aids in data extrapolation and initial concentration estimation for better pharmacokinetic modeling.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Computational Biology
  • Drug Development

Background:

  • Noncompartmental analysis (NCA) is crucial for characterizing drug behavior in the body.
  • Accurate calculation of area under the curve (AUC) and area under the first moment curve (AUMC) is essential for NCA.
  • Existing methods for data integration and extrapolation can be complex and time-consuming.

Purpose of the Study:

  • To introduce NCOMP, a user-friendly computer program for performing NCA of pharmacokinetic data.
  • To provide efficient and accurate methods for calculating key pharmacokinetic parameters.
  • To assist researchers in data handling, graphical display, and parameter estimation.

Main Methods:

  • NCOMP utilizes Lagrange polynomials or the Purves hybrid method (parabola-through-the-origin and log trapezoidal algorithms) for AUC and AUMC integration.

Related Experiment Videos

  • The program is designed for Microsoft Windows and integrates with spreadsheet software for data management and visualization.
  • Interactive features guide users in extrapolating data to infinity and estimating time zero concentrations for intravenous bolus administration.

    • Main Results:

    • NCOMP facilitates comprehensive noncompartmental analysis for various administration routes (iv bolus, continuous infusion, oral).
    • The program offers robust integration methods for accurate calculation of AUC and AUMC.
    • NCOMP provides interactive assistance for critical aspects of pharmacokinetic data analysis, including extrapolation and initial concentration estimation.

    Conclusions:

    • NCOMP is a valuable tool for researchers conducting pharmacokinetic studies, offering a streamlined approach to noncompartmental analysis.
    • The program enhances the accuracy and efficiency of pharmacokinetic data interpretation.
    • NCOMP's user-friendly interface and integration capabilities support effective drug development and research.